$ALT
Altimmune Inc

2020 Q2 Form 10-Q Financial Statement

#000156459020039314 Filed on August 11, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $721.6K $1.626M
YoY Change -55.62% -32.73%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.550M $2.230M
YoY Change 14.35% -23.89%
% of Gross Profit
Research & Development $16.59M $2.945M
YoY Change 463.45% -40.13%
% of Gross Profit
Depreciation & Amortization $60.66K $80.00K
YoY Change -24.17% 14.29%
% of Gross Profit
Operating Expenses $19.14M $2.945M
YoY Change 549.88% -62.5%
Operating Profit -$18.42M
YoY Change
Interest Expense $3.308K $748.00
YoY Change 342.25% -61.06%
% of Operating Profit
Other Income/Expense, Net $72.27K $164.0K
YoY Change -55.93% -103.15%
Pretax Income -$18.35M -$3.387M
YoY Change 441.67% -68.16%
Income Tax -$1.579M $0.00
% Of Pretax Income
Net Earnings -$16.77M -$3.387M
YoY Change 395.05% -62.94%
Net Earnings / Revenue -2323.46% -208.29%
Basic Earnings Per Share
Diluted Earnings Per Share -$937.4K -$258.2K
COMMON SHARES
Basic Shares Outstanding 13.45M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $80.20M $41.70M
YoY Change 92.33% 892.86%
Cash & Equivalents $64.78M $41.71M
Short-Term Investments $15.50M
Other Short-Term Assets $1.000M $700.0K
YoY Change 42.86% -46.15%
Inventory
Prepaid Expenses
Receivables $1.200M $2.600M
Other Receivables $5.500M $1.100M
Total Short-Term Assets $88.00M $46.11M
YoY Change 90.87% 288.55%
LONG-TERM ASSETS
Property, Plant & Equipment $1.700M $1.222M
YoY Change 39.1% -17.2%
Goodwill
YoY Change
Intangibles $13.76M
YoY Change -64.12%
Long-Term Investments
YoY Change
Other Assets $100.0K $156.1K
YoY Change -35.94% -62.04%
Total Long-Term Assets $14.50M $15.87M
YoY Change -8.64% -60.56%
TOTAL ASSETS
Total Short-Term Assets $88.00M $46.11M
Total Long-Term Assets $14.50M $15.87M
Total Assets $102.5M $61.98M
YoY Change 65.39% 18.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $200.0K $300.0K
YoY Change -33.33% 22.32%
Accrued Expenses $4.090M $3.047M
YoY Change 34.24% -42.58%
Deferred Revenue
YoY Change
Short-Term Debt $600.0K $0.00
YoY Change
Long-Term Debt Due $200.0K
YoY Change -84.62%
Total Short-Term Liabilities $4.900M $3.480M
YoY Change 40.79% -50.75%
LONG-TERM LIABILITIES
Long-Term Debt $1.715M $300.0K
YoY Change 471.67% -50.0%
Other Long-Term Liabilities $110.2K $2.000M
YoY Change -94.49% -45.95%
Total Long-Term Liabilities $1.825M $2.300M
YoY Change -20.64% -46.51%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.900M $3.480M
Total Long-Term Liabilities $1.825M $2.300M
Total Liabilities $23.00M $5.751M
YoY Change 299.93% -63.56%
SHAREHOLDERS EQUITY
Retained Earnings -$122.3M
YoY Change 35.94%
Common Stock $1.313K
YoY Change -64.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $79.52M $56.23M
YoY Change
Total Liabilities & Shareholders Equity $102.5M $61.98M
YoY Change 65.39% 18.95%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income -$16.77M -$3.387M
YoY Change 395.05% -62.94%
Depreciation, Depletion And Amortization $60.66K $80.00K
YoY Change -24.17% 14.29%
Cash From Operating Activities -$7.170M -$3.060M
YoY Change 134.31% -974.29%
INVESTING ACTIVITIES
Capital Expenditures -$80.00K -$20.00K
YoY Change 300.0% -88.24%
Acquisitions
YoY Change
Other Investing Activities $6.180M
YoY Change
Cash From Investing Activities $6.100M -$20.00K
YoY Change -30600.0% -88.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 54.54M -160.0K
YoY Change -34187.5% -95.38%
NET CHANGE
Cash From Operating Activities -7.170M -3.060M
Cash From Investing Activities 6.100M -20.00K
Cash From Financing Activities 54.54M -160.0K
Net Change In Cash 53.47M -3.240M
YoY Change -1750.31% -1.22%
FREE CASH FLOW
Cash From Operating Activities -$7.170M -$3.060M
Capital Expenditures -$80.00K -$20.00K
Free Cash Flow -$7.090M -$3.040M
YoY Change 133.22% -684.62%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 us-gaap Notes Payable Current
NotesPayableCurrent
632000
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
2750000
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3386888
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20652565
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.52
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
214921
CY2020Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-17079
CY2020Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
56739
CY2020Q1 alt Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
39974
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4581622
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1110659
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
743971
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
366688
CY2020Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
13529626
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1031323
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
718095
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
313228
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
110245
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
120196
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1864875
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4298299
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6162768
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
19139606
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-18417970
CY2019Q2 alt Changes In Fair Value Of Warrant Liability
ChangesInFairValueOfWarrantLiability
46000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-16766916
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-3386888
CY2020Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
20888
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-11547
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-16746028
CY2019Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-3386888
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-20664112
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-5484194
alt Deemed Dividends
DeemedDividends
452925
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-16766916
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5937119
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.94
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.25
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17886853
CY2020Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-32435
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
330510
CY2020Q2 alt Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
31270163
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
48312566
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
407714
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
36175
CY2020Q2 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-46389
CY2019Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
28
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
59322110
CY2019Q1 alt Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
30324
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-2097306
CY2019Q2 alt Stock Issued During Period Value Stock Based Compensation And Restricted Stock Vesting
StockIssuedDuringPeriodValueStockBasedCompensationAndRestrictedStockVesting
289800
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
71586
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
56225022
us-gaap Profit Loss
ProfitLoss
-20652565
us-gaap Profit Loss
ProfitLoss
-5484194
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
13640000
us-gaap Share Based Compensation
ShareBasedCompensation
545431
us-gaap Share Based Compensation
ShareBasedCompensation
697486
us-gaap Depreciation
Depreciation
120169
us-gaap Depreciation
Depreciation
121899
us-gaap Adjustment For Amortization
AdjustmentForAmortization
25876
us-gaap Adjustment For Amortization
AdjustmentForAmortization
107580
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
18851
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
24943
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
46000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
160920
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-832098
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
343337
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
113200
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
176985
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-102763
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
26761
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1181457
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
4877851
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11518302
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5173080
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
24900000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
12118563
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
40601
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1226
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
79336
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
15874
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
12661500
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17100
alt Payments Of Deferred Offering Costs
PaymentsOfDeferredOfferingCosts
179743
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
31310137
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
30324
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
22780729
us-gaap Proceeds From Issuance Of Common Limited Partners Units
ProceedsFromIssuanceOfCommonLimitedPartnersUnits
12668784
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
632000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
56739
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
36175
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
156145
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
54636037
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12542963
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
55779235
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7352783
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34353129
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
41705912
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:6.25%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The extent to which the COVID-19 pandemic may directly or indirectly impact the Company&#8217;s business, financial condition, and results of operations is highly uncertain and subject to change. The Company considered the potential impact of the COVID-19 pandemic on the Company&#8217;s estimates and assumptions and determined that there was not a material impact to the Company&#8217;s consolidated financial statements as of and for the three and six months ended June 30, 2020. However, actual results could differ from those estimates and there may be changes to the Company&#8217;s estimates in future periods.</p>
CY2019Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
13450290
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
20596
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
27687
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
27687
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
27687
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
23781
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
239250
CY2020Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
472329
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
956584
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
429467
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1183130
CY2020Q2 us-gaap Interest Payable Current
InterestPayableCurrent
10240
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
5047
CY2020Q2 alt Accrued Research And Development
AccruedResearchAndDevelopment
2343629
CY2019Q4 alt Accrued Research And Development
AccruedResearchAndDevelopment
1966111
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
273276
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
259449
CY2020Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
33691
CY2019Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
61563
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4089749
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3904767
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1344779
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1484679
CY2020Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
10000
CY2019Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
10000
CY2020Q2 alt Economic Conditional Incentive Grants
EconomicConditionalIncentiveGrants
250000
CY2019Q4 alt Economic Conditional Incentive Grants
EconomicConditionalIncentiveGrants
250000
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1715024
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10384706
alt Number Of Warrants Issued Due To Anti Dilution Features Triggered From Registered Direct Offering
NumberOfWarrantsIssuedDueToAntiDilutionFeaturesTriggeredFromRegisteredDirectOffering
1358
alt Number Of Warrants Exercised For Conversion Of Securities
NumberOfWarrantsExercisedForConversionOfSecurities
8235779
CY2020Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2150285
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1477153
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
416022
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1061131
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.65
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.97
alt Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedOutstandingWeightedAverageExercisePrice
2.74
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y11M15D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y8M8D
alt Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedOutstandingWeightedAverageRemainingContractualTerm
P6Y25D
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
12804940
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
3097502
CY2020Q2 alt Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOutstandingIntrinsicValue
9707438
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
330510
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
289772
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
545431
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
697486
alt Non Cancellable Lease Maturity Period
NonCancellableLeaseMaturityPeriod
2022-12
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
173894
CY2019Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
83903
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
174079
CY2020Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
64193
us-gaap Operating Lease Payments
OperatingLeasePayments
126073
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1618055
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y9M29D
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.080
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
194596
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
393542
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
400198
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
407054
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
414116
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
138831
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1948337
alt Effective Income Tax Rate Reconciliation Additional Discrete Item Of Income Tax Benefit
EffectiveIncomeTaxRateReconciliationAdditionalDiscreteItemOfIncomeTaxBenefit
1000000
CY2020Q2 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
-1000000
CY2020Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
15475942
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
330282
CY2020Q2 us-gaap Income Tax Examination Liability Refund Adjustment From Settlement With Taxing Authority
IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority
2900000
CY2020Q2 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
8460
CY2020Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
15484402
CY2020Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2019Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2019Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2019Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2020Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2019Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0

Files In Submission

Name View Source Status
0001564590-20-039314-index-headers.html Edgar Link pending
0001564590-20-039314-index.html Edgar Link pending
0001564590-20-039314.txt Edgar Link pending
0001564590-20-039314-xbrl.zip Edgar Link pending
alt-10q_20200630.htm Edgar Link pending
alt-20200630.xml Edgar Link completed
alt-20200630.xsd Edgar Link pending
alt-20200630_cal.xml Edgar Link unprocessable
alt-20200630_def.xml Edgar Link unprocessable
alt-20200630_lab.xml Edgar Link unprocessable
alt-20200630_pre.xml Edgar Link unprocessable
alt-ex102_335.htm Edgar Link pending
alt-ex103_571.htm Edgar Link pending
alt-ex311_6.htm Edgar Link pending
alt-ex312_7.htm Edgar Link pending
alt-ex321_8.htm Edgar Link pending
alt-ex322_9.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gxgpyldmzs5j000001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending